Researchers develop mathematical model to predict effective dosage range of cancer treatment

FHS
May 28, 2024
11:46 am

Cancer poses significant challenges due to the development of resistance and the likelihood of relapse. Resistance may arise from permanent genetic changes in cancer cells or non-genetic alterations in cancer cell behavior induced by treatment.

IBD Surgery Linked to Improved Patient-Reported Pain, Physical Health

LAS VEGAS — Patients who underwent surgery for inflammatory bowel disease (IBD) reported feeling physically better, but not emotionally or socially better, 1 month after

February 1, 2024

Study finds fourfold increase in risk of overt hypothyroidism after diagnosis of gestational subclinical hypothyroidism

A new study has shown that subclinical hypothyroidism diagnosed before 21 weeks of pregnancy is associated with more than fourfold higher rates of overt hypothyroidism

August 2, 2024

FDA is poised to pull Ocaliva as adcomm documents question post-approval study results

The FDA appeared ready to pull its accelerated approval of Alfasigma and Intercept Pharmaceuticals’ rare liver disease drug Ocaliva, bluntly laying out its rationale in

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.